Search
for
Sort by
Research 31–60 of 1000+
- Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
- The Adapted Classification of Male Pattern Hair Loss Improves Reliability
- Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction
- Differences in male and female pattern hair loss based on androgens, estrogen, iron, vitamin D, lipid metabolism, and genetic regulation
- Efficacy and safety of oral minoxidil in comparison to topical form in male pattern hair loss
- A Novel Approach Against Male Pattern Hair Loss With Topical Dimethylglycine Sodium Salt (DMG‐Na) and Caffeine: Efficacy of a 24‐Week, Double‐Blind, Randomized, Placebo‐Controlled Trial
- Comparative Efficacy of Minoxidil and 5‐Alpha Reductase Inhibitors Monotherapy for Male Pattern Hair Loss: Network Meta‐Analysis Study of Current Empirical Evidence
- Short anagen hair syndrome is caused by mutations in the <i>WNT10A</i> gene and has a genetic overlap with male pattern hair loss
- The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial
- Clinical Use of Extracellular Vesicles in the Management of Male and Female Pattern Hair Loss: A Preliminary Retrospective Institutional Review Board Safety and Efficacy Study
- Faculty Opinions recommendation of Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?
- The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride
- Medical treatments for male and female pattern hair loss
- Prevalence of Male and Female Pattern Hair Loss in Maryborough
- Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- The current role of laser/light sources in the treatment of male and female pattern hair loss
- Male pattern hair loss: current understanding
- Prevalence of Male Pattern Hair Loss in 18–49 Year Old Men
- Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss
- Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair loss
- Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)
- Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version
- Male-Pattern Hair Loss in Norwegian Men: A Community-Based Study
- Quality of Life Issues in Male Pattern Hair Loss
- Autologous cell–based therapy for male and female pattern hair loss using dermal sheath cup cells: A randomized placebo-controlled double-blinded dose-finding clinical study
- Attitudes, behaviors, and expectations of men seeking medical treatment for male pattern hair loss: results of a multinational survey
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Dermal fibrosis in male pattern hair loss: a suggestive implication of mast cells
- Medical management of male pattern hair loss